UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
121.48
+1.89 (1.58%)
Sep 22, 2025, 3:57 PM EDT
UCB SA Market Cap
UCB SA has a market cap or net worth of $46.17 billion as of September 23, 2025. Its market cap has increased by 37.16% in one year.
Market Cap
46.17B
Enterprise Value
47.67B
Revenue
8.04B
Ranking
n/a
PE Ratio
29.52
Stock Price
$121.48
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 46.17B, an increase of 3,745.72%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 45.37B | 20.18% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 667.60M |
| Glass House Brands | 551.67M |
| Northwest Biotherapeutics | 376.65M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 367.01M |
| American Oncology Network | 347.09M |